OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.190
-0.020 (-0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
OncoCyte Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$4.42
Upside
+101.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Oct 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | Aug 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +94.06% | May 16, 2024 |
| Needham | Needham | Strong Buy Maintains $3.6 → $4.25 | Strong Buy | Maintains | $3.6 → $4.25 | +94.06% | Apr 24, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +82.65% | Apr 17, 2024 |
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +128.31% | Apr 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $3.5 → $3 | Hold | Maintains | $3.5 → $3 | +36.99% | Nov 13, 2023 |
| Needham | Needham | Strong Buy Maintains $4.25 → $3.6 | Strong Buy | Maintains | $4.25 → $3.6 | +64.38% | Nov 9, 2023 |
| Benchmark | Benchmark | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +128.31% | Aug 24, 2023 |
| Piper Sandler | Piper Sandler | Hold Maintains $6 → $3.5 | Hold | Maintains | $6 → $3.5 | +59.82% | Aug 15, 2023 |
| Needham | Needham | Strong Buy Maintains $9 → $4.25 | Strong Buy | Maintains | $9 → $4.25 | +94.06% | Aug 10, 2023 |
| Needham | Needham | Strong Buy Maintains $28 → $9 | Strong Buy | Maintains | $28 → $9 | +310.96% | Apr 4, 2023 |
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $60 → $10 | Strong Buy → Hold | Downgrades | $60 → $10 | +356.62% | Dec 1, 2022 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $10 | Buy → Hold | Downgrades | $20 → $10 | +356.62% | Nov 18, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +813.24% | Nov 14, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.